US Patent 11918651 Formulations of antibody molecules to dengue virus
Patent 11918651 was granted and assigned to Visterra Inc. on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+48 properties)
Article (+170 characters)
US Patent 11918651 Formulations of antibody molecules to dengue virus
Article
Patent abstract
Formulations of peptide agents, such as antibodies and antigen-binding fragments thereof, that bind dengue viruses, and methods of their use, are provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Bi Xu0
Catherine Hay0
Susan Sloan0
Date of Patent
March 5, 2024
0Patent Application Number
165962390
Date Filed
October 8, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11918651 Formulations of antibody molecules to dengue virus
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
